180 related articles for article (PubMed ID: 9150524)
1. Photodynamic therapy for choriocapillaris using tin ethyl etiopurpurin (SnET2).
Peyman GA; Moshfeghi DM; Moshfeghi A; Khoobehi B; Doiron DR; Primbs GB; Crean DH
Ophthalmic Surg Lasers; 1997 May; 28(5):409-17. PubMed ID: 9150524
[TBL] [Abstract][Full Text] [Related]
2. Ocular vascular thrombosis following tin ethyl etiopurpurin (SnET2) photodynamic therapy: time dependencies.
Moshfeghi DM; Peyman GA; Moshfeghi AA; Khoobehi B; Primbs GB; Crean DH
Ophthalmic Surg Lasers; 1998 Aug; 29(8):663-8. PubMed ID: 9715492
[TBL] [Abstract][Full Text] [Related]
3. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).
Mori K; Yoneya S; Ohta M; Sano A; Anzai K; Peyman GA; Moshfeghi DM
Ophthalmology; 1999 Jul; 106(7):1384-91. PubMed ID: 10406627
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy for corneal neovascularization.
Primbs GB; Casey R; Wamser K; Snyder WJ; Crean DH
Ophthalmic Surg Lasers; 1998 Oct; 29(10):832-8. PubMed ID: 9793949
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy of the ciliary body with tin ethyl etiopurpurin and tin octaethyl benzochlorin in pigmented rabbits.
Hill RA; Crean DH; Doiron DR; Ghosheh F; Ryan JA; Kelly H; Booth M; Liaw LH; Newman L; Berns MW
Ophthalmic Surg Lasers; 1997 Nov; 28(11):948-53. PubMed ID: 9387183
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy for antifibrosis in a rabbit model of filtration surgery.
Hill RA; Crean DH; Doiron DR; McDonald TJ; Liaw LH; Ghosheh F; Hamilton A; Berns MW
Ophthalmic Surg Lasers; 1997 Jul; 28(7):574-81. PubMed ID: 9243661
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the new photosensitizer Tookad (WST09) for photodynamic vessel occlusion of the choroidal tissue in rabbits.
Framme C; Sachs HG; Flucke B; Theisen-Kunde D; Birngruber R
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5437-46. PubMed ID: 17122134
[TBL] [Abstract][Full Text] [Related]
8. Studies of tin ethyl etiopurpurin photodynamic therapy of the canine prostate.
Selman SH; Albrecht D; Keck RW; Brennan P; Kondo S
J Urol; 2001 May; 165(5):1795-801. PubMed ID: 11342978
[TBL] [Abstract][Full Text] [Related]
9. Threshold and retreatment parameters of NPe6 photodynamic therapy in retinal and choroidal vessels.
Peyman GA; Kazi AA; Moshfeghi D; Unal M; Khoobehi B; Yoneya S; Mori K; Rivera I
Ophthalmic Surg Lasers; 2000; 31(4):323-7. PubMed ID: 10928670
[TBL] [Abstract][Full Text] [Related]
10. Photothrombosis of retinal and choroidal vessels in rabbit eyes using chloroaluminum sulfonated phthalocyanine and a diode laser.
Iliaki OE; Naoumidi II; Tsilimbaris MK; Pallikaris IG
Lasers Surg Med; 1996; 19(3):311-23. PubMed ID: 8923426
[TBL] [Abstract][Full Text] [Related]
11. Experimental photodynamic effects of hypocrellin A on the choriocapillaris.
Khoobehi B; Grinstead R; Passos E
Ophthalmic Surg Lasers; 2002; 33(3):207-13. PubMed ID: 12027100
[TBL] [Abstract][Full Text] [Related]
12. PDT to monkey CNV with ATX-S10(Na): inappropriateness of early laser irradiation for selective occlusion.
Obana A; Gohto Y; Kaneda K; Nakajima S; Miki T
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2639-45. PubMed ID: 11581211
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin.
Miller JW; Walsh AW; Kramer M; Hasan T; Michaud N; Flotte TJ; Haimovici R; Gragoudas ES
Arch Ophthalmol; 1995 Jun; 113(6):810-8. PubMed ID: 7540388
[TBL] [Abstract][Full Text] [Related]
14. Threshold power levels for NPe6 photodynamic therapy.
Kazi AA; Peyman GA; Unal M; Khoobehi B; Yoneya S; Mori K; Moshfeghi D; Moshfeghi AA
Ophthalmic Surg Lasers; 2000; 31(2):136-42. PubMed ID: 10743925
[TBL] [Abstract][Full Text] [Related]
15. [Selective occlusion of subretinal neovascularization with photodynamic therapy].
Schmidt-Erfurth U; Hasan T; Gragoudas E; Birngruber R
Ophthalmologe; 1994 Dec; 91(6):789-95. PubMed ID: 7849433
[TBL] [Abstract][Full Text] [Related]
16. Scanning laser system for photodynamic therapy of choroidal neovascularization.
Obana A; Gohto Y
Lasers Surg Med; 2002; 30(5):370-5. PubMed ID: 12116330
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of photodynamic occlusion using liposomal Zn(II)-phtalocyanine.
Schmidt-Erfurth U; Michels S; Indorf L; Eggers R; Birngruber R
Curr Eye Res; 2005 Jul; 30(7):601-12. PubMed ID: 16020295
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of experimentally induced choroidal neovascularizations in pigmented rabbits by subretinal injection of lipid hydroperoxide and consecutive preliminary photodynamic treatment with Tookad.
Framme C; Sachs HG; Kobuch K; Flucke B; Birngruber R
Ophthalmologica; 2008; 222(4):254-64. PubMed ID: 18525218
[TBL] [Abstract][Full Text] [Related]
19. Spatial distribution of liposome encapsulated tin etiopurpurin dichloride (SnET2) in the canine prostate: implications for computer simulation of photodynamic therapy.
Aniola J; Selman SH; Lilge L; Keck R; Jankun J
Int J Mol Med; 2003 Mar; 11(3):287-91. PubMed ID: 12579328
[TBL] [Abstract][Full Text] [Related]
20. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes.
Schlötzer-Schrehardt U; Viestenz A; Naumann GO; Laqua H; Michels S; Schmidt-Erfurth U
Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):748-57. PubMed ID: 12271373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
